accountMay 5 (Bloomberg) -- GlaxoSmithKline Plc, after setting aside more than $6 billion to help settle lawsuits over medicines including its Avandia diabetes drug, is poised to resolve 1,000 more cases, a lawyer for...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Glaxo May Settle 1,000 More Avandia Lawsuits, Attorney Says
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account